This Law Week 2015 chapter focuses on how technology and intellectual property law affects a variety of fields, especially the biotech industry.

  • Patent eligibility in the biotechnology industry

    The Supreme Court decisions in Mayo Collaborative Services v Prometheus Laboratories Inc. (2012) Ass’n for Molecular Pathology v Myriad Genetics Inc. (2013) altered the scope of patentable subject matter by redefining patent eligible subject matter. While isolated DNA and methods of diagnosis remain patentable in most of the world, in the United States, the scope of such claims, which contributed to the success of biotechnology companies, has been limited.

  • 2014 sees spike in lawsuits for pharma patents

    Litigation stemming from filings of Abbreviated New Drug Applications was stable from 2007 through 2013, oscillating between 203 and 294 a year, which makes 2014’s jump to 432 cases stick out like a sore thumb. What isn’t so clear is what the increase stems from, and whether it’s a sign of things to come or a fluke.

  • Patent eligibility update brings slight improvements for biotech

    After getting an earful from patent lawyers and biotech companies upset that the initial U.S. Patent and Trademark Office’s guidance on subject eligibility for naturally occurring products — think DNA and protein mutations — was released without first seeking comment, the office released a revised version in December.

  • Patent reform will hurt system in the guise of preventing ‘trolls,’ experts say

    Congress is considering controversial patent reform to reduce abusive practices by so-called “patent trolls,” people who build up a portfolio of broad-based patents with the aim of suing alleged infringers, as opposed to actually creating products with the patents.

  • Kim Kardashian, Kanye West video-leak lawsuit can proceed

    LOS ANGELES -- Kim Kardashian and Kanye West's lawsuit against the co-founder of YouTube over leaked footage of their marriage proposal should move forward, a California appeals court ruled April 22.

  • Three firms take roles in hostile pharma bids

    With three pharmaceutical companies -- Teva Pharmaceutical Industries Ltd., Mylan NV and Perrigo Co. -- sparring over competing takeover bids, it’s not surprising that the three have hired firms big in the M&A space.

  • Judge says Vermont law on genetically modified food stands

    MONTPELIER, Vt. -- A Vermont law that could make the state the first in the country to require labeling of genetically modified food has been allowed to stand for now despite opposition by food industry groups.

  • Fired L’Oreal lawyer says patent push was only cosmetic

    Call it the case of “patent or perish.”

Related Reports

Law Week - 2015 (Full Report)

The Daily Transcript honors Law Week with a weeklong series celebrating the business of law. Coverage includes stories on important issues like civil rights, real estate and construction, intellectual property, and legal education.

Law Week -- Education & Legal Services - 2015

This Law Week 2015 chapter highlights education and legal services.

Law Week -- Constitutional Law & Civil Rights - 2015

The Daily Transcript honors this year's national Law Week theme with a look at some of the latest issues concerning constitutional law and civil rights.

Law Week -- Real Estate & Construction - 2015

Law Week 2015 continues with a look at the latest real estate and construction legal issues.

Law Week -- Corporate & Employment Law - 2015

This chapter of Law Week 2015 focuses on corporate and employment law.

Archived Reports

Law Week - 2015

The Daily Transcript honors Law Week with a weeklong series celebrating the business of law. Coverage includes stories on important issues like civil rights, real estate and construction, intellectual property, and legal education.